A detailed history of Advisor Partners Ii, LLC transactions in Amgen Inc stock. As of the latest transaction made, Advisor Partners Ii, LLC holds 30,523 shares of AMGN stock, worth $9.85 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
30,523
Previous 28,777 6.07%
Holding current value
$9.85 Million
Previous $6.39 Million 28.39%
% of portfolio
0.33%
Previous 0.3%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

BUY
$218.65 - $271.46 $381,762 - $473,969
1,746 Added 6.07%
30,523 $8.2 Million
Q2 2023

Aug 10, 2023

SELL
$214.27 - $253.37 $17,141 - $20,269
-80 Reduced 0.28%
28,777 $6.39 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $245,885 - $299,692
1,089 Added 3.92%
28,857 $6.98 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $906,958 - $1.15 Million
3,960 Added 16.63%
27,768 $7.29 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $5.34 Million - $6.03 Million
23,808 New
23,808 $5.37 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $173B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Advisor Partners Ii, LLC Portfolio

Follow Advisor Partners Ii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners Ii, LLC with notifications on news.